Upgrade to SI Premium - Free Trial

Form 4 Destination Maternity For: Sep 13 Filed by: Courtright David L

September 15, 2017 4:28 PM
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Courtright David L
(Last) (First) (Middle)
C/O DESTINATION MATERNITY CORPORATION
232 STRAWBRIDGE DRIVE
(Street)
MOORESTOWN NJ 08057
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Destination Maternity Corp [ DEST ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Principal Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/13/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/13/2017 S 2,600 D $ 1.28 20,757.7523 (1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 3.515 (2) 11/19/2018 Common Stock 200 200 D
Stock Options (Right to Buy) $ 11.89 (3) 01/29/2020 Common Stock 400 400 D
Stock Options (Right to Buy) $ 22.13 (4) 03/03/2021 Common Stock 600 600 D
Stock Options (Right to Buy) $ 14.51 (5) 11/18/2021 Common Stock 1,500 1,500 D
Stock Options (Right to Buy) $ 19.89 (6) 11/16/2022 Common Stock 2,000 2,000 D
Stock Options (Right to Buy) $ 31.38 (7) 11/22/2023 Common Stock 1,500 1,500 D
Stock Options (Right to Buy) $ 14.3 (8) 12/05/2024 Common Stock 7,980 7,980 D
Stock Options (Right to Buy) $ 7.49 (9) 03/30/2026 Common Stock 13,300 13,300 D
Explanation of Responses:
1. Includes 7,358 shares of unvested restricted stock. This includes 375 shares from the November 22, 2013 grant of 1,500 shares, which shares vest in four (4) equal annual installments beginning on November 22, 2014; 1,995 shares from the December 5, 2014 grant of 3,990 shares, which shares vest in annual installments over a four (4) year period beginning on December 5, 2015 as follows: 997 shares vest on each of December 5, 2015 and December 5, 2017, and 998 shares vest on each of December 5, 2016 and December 5, 2018; 4,988 shares from the March 30, 2016 grant of 6,650 shares, which shares vest in annual installments over a four (4) year period beginning on March 30, 2017 as follows: 1,662 shares vest on each of March 30, 2017 and March 30, 2019, and 1,663 shares vest on each of March 30, 2018 and March 30, 2020. 2,714.7523 of these shares were purchased by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.
2. On November 19, 2008, options to purchase 1,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on November 19, 2009. All of the remaining outstanding November 19, 2008 options are vested.
3. On January 29, 2010, options to purchase 1,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on January 29, 2011. All of the remaining outstanding January 29, 2010 options are vested.
4. On March 3, 2011, options to purchase 1,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on March 3, 2012. All of the remaining outstanding March 3, 2011 options are vested.
5. On November 18, 2011, options to purchase 2,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 18, 2012. All of the remaining outstanding November 18, 2011 options are vested.
6. On November 16, 2012, options to purchase 2,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 16, 2013. All of the outstanding November 16, 2012 options are vested.
7. On November 22, 2013, options to purchase 1,500 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 22, 2014. 1,125 of the outstanding November 22, 2013 options are vested and 375 are unvested.
8. On December 5, 2014, options to purchase 7,980 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on December 5, 2015. 3,990 of the outstanding December 5, 2014 options are vested and 3,990 are unvested.
9. On March 30, 2016, options to purchase 13,300 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on March 30, 2017. 3,325 of the outstanding March 30, 2016 options are vested and 9,975 are unvested.
David L. Courtright 09/15/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings